Credit Suisse Starts Spectrum Pharmaceuticals (SPPI) at Neutral
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 6
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 6
Join SI Premium – FREE
Credit Suisse initiates coverage on Spectrum Pharmaceuticals (NASDAQ: SPPI) with a Neutral. PT $15.00.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $12.67 yesterday.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $12.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Benchmark Starts Allegro MicroSystems (ALGM) at Buy
- Nomura/Instinet Starts Shenzhen Megmeet Electrical (002851:CH) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
